Explore

Trendline Trendline
Charles River Laboratories to Present at Major Conferences

Charles River Laboratories to Present at Major Conferences

Charles River Laboratories to Present at Major Conferences
Trendline Trendline
Charles River Laboratories to Present Strategic Focus at Major Conferences

Charles River Laboratories to Present Strategic Focus at Major Conferences

Charles River Laboratories to Present Strategic Focus at Major Conferences
Trendline Trendline
PromptSE AI Framework Enhances Drug Side Effect Prediction by Leveraging Biological Clues

PromptSE AI Framework Enhances Drug Side Effect Prediction by Leveraging Biological Clues

PromptSE AI Framework Enhances Drug Side Effect Prediction by Leveraging Biological Clues
Trendline Trendline
Eli Lilly Partners with Haisco in $3 Billion Deal for Early-Stage Drug Development

Eli Lilly Partners with Haisco in $3 Billion Deal for Early-Stage Drug Development

Eli Lilly Partners with Haisco in $3 Billion Deal for Early-Stage Drug Development
Trendline Trendline
CordenPharma Acquires AmbioPharm to Enhance Peptide Production Capabilities

CordenPharma Acquires AmbioPharm to Enhance Peptide Production Capabilities

CordenPharma Acquires AmbioPharm to Enhance Peptide Production Capabilities
Trendline Trendline
Corsair Pharma Reports Positive Phase 1 Results for TRX-248 Transdermal System in PAH Treatment

Corsair Pharma Reports Positive Phase 1 Results for TRX-248 Transdermal System in PAH Treatment

Corsair Pharma Reports Positive Phase 1 Results for TRX-248 Transdermal System in PAH Treatment
Trendline Trendline
ENYO Pharma Appoints Jeff George as Chairman to Lead Phase 3 Development

ENYO Pharma Appoints Jeff George as Chairman to Lead Phase 3 Development

ENYO Pharma Appoints Jeff George as Chairman to Lead Phase 3 Development
Trendline Trendline
AstraZeneca Seeks FDA Approval for Camizestrant in Breast Cancer Treatment Despite Advisory Committee Setback

AstraZeneca Seeks FDA Approval for Camizestrant in Breast Cancer Treatment Despite Advisory Committee Setback

AstraZeneca Seeks FDA Approval for Camizestrant in Breast Cancer Treatment Despite Advisory Committee Setback
Trendline Trendline
Corsair Pharma Reports Positive Phase 1 Results for TRX-248 Transdermal System in Pulmonary Arterial Hypertension

Corsair Pharma Reports Positive Phase 1 Results for TRX-248 Transdermal System in Pulmonary Arterial Hypertension

Corsair Pharma Reports Positive Phase 1 Results for TRX-248 Transdermal System in Pulmonary Arterial Hypertension
Trendline Trendline
Seaport Therapeutics to Present at Major Investor Conferences in June 2026

Seaport Therapeutics to Present at Major Investor Conferences in June 2026

Seaport Therapeutics to Present at Major Investor Conferences in June 2026
Trendline Trendline
Ardena Appoints Ariane de Ganck as Chief Scientific Officer to Enhance Drug Development

Ardena Appoints Ariane de Ganck as Chief Scientific Officer to Enhance Drug Development

Ardena Appoints Ariane de Ganck as Chief Scientific Officer to Enhance Drug Development
Trendline Trendline
AeroVironment to Invest $15 Million in Dayton Expansion, Creating 200 Jobs

AeroVironment to Invest $15 Million in Dayton Expansion, Creating 200 Jobs

AeroVironment to Invest $15 Million in Dayton Expansion, Creating 200 Jobs